Literature DB >> 18628251

Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression.

Tamara Cacev1, Senka Radosević, Simun Krizanac, Sanja Kapitanović.   

Abstract

Cytokines produced in the tumour microenvironment have an important role in cancer pathogenesis. Altered cytokine expression may result in increased susceptibility to and/or poor prognosis in certain cancers. Therefore, the aim of this study was to investigate the influence of interleukin (IL)-8 and IL-10 on sporadic colon cancer development and progression. In our study, a statistically significant increase in IL-8 messenger RNA (mRNA) expression and decrease in IL-10 mRNA expression in tumour tissue compared with normal mucous tissue was observed (P = 0.003; P = 1.3 x 10(-9)). No association was found between IL-8 -251 A/T genotypes and IL-8 mRNA expression in tumour and corresponding normal mucous tissue, as well as susceptibility to sporadic colon cancer. Positive immunohistochemical IL-8 staining was more frequent in moderately and poorly differentiated tumours compared with well-differentiated tumours (P = 0.024). Finally, IL-8 significantly stimulated invasion of HT-29 cells in vitro (P = 0.000172). Significant association of IL-10 -1082 A/G, -819 T/C and -592 A/C genotypes and IL-10 mRNA expression in tumour tissue was observed (P = 0.022; P = 0.013; P = 0.02). Significant association of -819 T/C and -592 A/C genotypes and IL-10 mRNA expression in corresponding normal mucous tissue was observed (P = 0.01; P = 0.04) as well. IL-10 single-nucleotide polymorphism (SNP) promoter genotypes associated with low IL-10 mRNA expression (-819 TT; -592 AA) were also associated with increased risk of sporadic colon cancer compared with high-expression genotypes [odds ratio, 5.53; 95% confidence interval (CI), 1.53-20.1; odds ratio, 4.07; 95% CI, 1.28-12.96]. Positive IL-10 immunohistochemical reaction was more frequent in well-differentiated and moderately differentiated tumours compared with poorly differentiated tumours (P = 0.036). In Dukes' C tumours, positive IL-10 immunohistochemical reaction was less frequent compared with Dukes' A and B tumours (P = 0.023). Taken together, our results point to possible tumour promoting role of IL-8 and potential protective role of IL-10 in sporadic colon cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18628251     DOI: 10.1093/carcin/bgn164

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  40 in total

1.  The polymorphism interleukin-8 -251A/T is associated with a significantly increased risk of cancers from a meta-analysis.

Authors:  Ziliang Wang; Yang Liu; Lina Yang; Sheng Yin; Rongyu Zang; Gong Yang
Journal:  Tumour Biol       Date:  2014-04-24

2.  Custom design of a GeXP multiplexed assay used to assess expression profiles of inflammatory gene targets in normal colon, polyp, and tumor tissue.

Authors:  Janice E Drew; Claus-Dieter Mayer; Andrew J Farquharson; Pauline Young; Lawrence N Barrera
Journal:  J Mol Diagn       Date:  2011-03       Impact factor: 5.568

3.  Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas.

Authors:  Xiao-Bing Wang; Xiao-Ying Tian; Yang Li; Bin Li; Zhi Li
Journal:  J Neurooncol       Date:  2011-07-03       Impact factor: 4.130

4.  -251 T/A polymorphism of the interleukin-8 gene and cancer risk: a HuGE review and meta-analysis based on 42 case-control studies.

Authors:  Na Wang; Rongmiao Zhou; Chunmei Wang; Xiaoqing Guo; Zhifeng Chen; Shan Yang; Yan Li
Journal:  Mol Biol Rep       Date:  2011-06-17       Impact factor: 2.316

5.  Prognostic importance of single-nucleotide polymorphisms in IL-6, IL-10, TGF-β1, IFN-γ, and TNF-α genes in chronic phase chronic myeloid leukemia.

Authors:  Mustafa Pehlivan; Handan Haydaroglu Sahin; Sacide Pehlivan; Kursat Ozdilli; Leylagul Kaynar; Fatma Savran Oguz; Tugce Sever; Mehmet Yilmaz; Bulent Eser; Yeliz Duvarci Ogret; Cem Kis; Vahap Okan; Mustafa Cetin; Mahmut Carin
Journal:  Genet Test Mol Biomarkers       Date:  2014-05-12

6.  Genetic variation in the inflammation and innate immunity pathways and colorectal cancer risk.

Authors:  Hansong Wang; Darin Taverna; Daniel O Stram; Barbara K Fortini; Iona Cheng; Lynne R Wilkens; Terrilea Burnett; Karen W Makar; Noralane M Lindor; John L Hopper; Steve Gallinger; John A Baron; Robert Haile; Laurence N Kolonel; Brian E Henderson; Polly A Newcomb; Graham Casey; David Duggan; Cornelia M Ulrich; Loïc Le Marchand
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-17       Impact factor: 4.254

Review 7.  Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways.

Authors:  Aaron J Schetter; Niels H H Heegaard; Curtis C Harris
Journal:  Carcinogenesis       Date:  2009-12-02       Impact factor: 4.944

8.  Tandutinib inhibits the Akt/mTOR signaling pathway to inhibit colon cancer growth.

Authors:  Sivapriya Ponnurangam; David Standing; Parthasarathy Rangarajan; Dharmalingam Subramaniam
Journal:  Mol Cancer Ther       Date:  2013-02-20       Impact factor: 6.261

9.  The lL-8 and IL-13 gene polymorphisms in inflammatory bowel disease and colorectal cancer.

Authors:  Anna Walczak; Karolina Przybylowska; Lukasz Dziki; Andrzej Sygut; Cezary Chojnacki; Jan Chojnacki; Adam Dziki; Ireneusz Majsterek
Journal:  DNA Cell Biol       Date:  2012-06-28       Impact factor: 3.311

10.  Mice that express human interleukin-8 have increased mobilization of immature myeloid cells, which exacerbates inflammation and accelerates colon carcinogenesis.

Authors:  Samuel Asfaha; Alexander N Dubeykovskiy; Hiroyuki Tomita; Xiangdong Yang; Sarah Stokes; Wataru Shibata; Richard A Friedman; Hiroshi Ariyama; Zinaida A Dubeykovskaya; Sureshkumar Muthupalani; Russell Ericksen; Harold Frucht; James G Fox; Timothy C Wang
Journal:  Gastroenterology       Date:  2012-10-03       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.